The Middle EAST Pharmaceutical Injectables Market was valued at USD 8.5 billion in 2024 and is projected to reach USD 15.2 billion by 2034, registering a CAGR of 6.1%. This growth trajectory is underpinned by several factors, including an increasing prevalence of chronic diseases, a rising geriatric population, and advancements in drug delivery systems. The demand for injectable pharmaceuticals...